🇺🇸 FDA
Patent

US 6720344

Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants

expired A61KA61K31/428A61K31/47

Quick answer

US patent 6720344 (Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants) held by The Board of Regents of the University of Texas System expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/428, A61K31/47, A61P, A61P19/10